Table 1.
Descriptive characteristics of participants.
| Cases (N = 139) |
Controls (N = 107) |
P-value | |||
|---|---|---|---|---|---|
| N | (%) | N | (%) | ||
| Age (years) | |||||
| <60 | 38 | (27.3) | 23 | (21.5) | 0.335a |
| 60–69.9 | 50 | (35.9) | 48 | (44.9) | |
| 70+ | 51 | (36.7) | 36 | (33.6) | |
| BMI (kg/m2) | |||||
| <25 | 22 | (15.8) | 31 | (28.9) | <0.001a |
| 25–29.9 | 40 | (28.8) | 38 | (35.5) | |
| 30+ | 72 | (51.8) | 29 | (27.1) | |
| Menopausal status | |||||
| Premenopausal | 6 | (4.3) | 9 | (8.4) | 0.092b |
| Perimenopausal | 7 | (5.0) | 1 | (0.9) | |
| Postmenopausal | 126 | (90.7) | 97 | (90.7) | |
| Abnormal bleeding | |||||
| Yes | 124 | (89.2) | 43 | (40.2) | <0.001a |
| No | 15 | (10.8) | 47 | (43.9) | |
| MMR status | |||||
| Proficient | 110 | (79.1) | NA | NA | |
| Deficient | 24 | (17.3) | NA | ||
| TVU | |||||
| Normal | 13 | (9.4) | 41 | (38.3) | <0.001a |
| Abnormal | 119 | (85.6) | 47 | (43.9) | |
| Stage | |||||
| I-II | 111 | (79.9) | NA | NA | |
| III-IV | 27 | (19.4) | NA | ||
| Grade | |||||
| 1 | 61 | (43.9) | NA | NA | |
| 2 | 16 | (11.5) | NA | ||
| 3 | 62 | (44.6) | NA | ||
| Histology | |||||
| Endometrioid | 98 | (70.5) | NA | NA | |
| Non-endometrioid | 41 | (29.5) | NA | ||
| Collection | |||||
| Clinician-collected | 129 | (92.8) | 99 | (92.5) | <0.001a |
| Self-collected | 90 | (64.7) | 21 | (19.6) | |
NA = Not Applicable; BMI = Body mass index; MMR = Mismatch repair; TVU = Transvaginal ultrasound.
Numbers are not up to the total due to missing values.
a
Chi-squared, comparing cases and controls.
b
Fisher exact test.